Title of Collaborative Activity: |
FDA Medical Countermeasures initiative (MCMi) Regulatory Science Steering Committee |
Description of Collaborative Activity: |
This committee provides guidance to MCMi stakeholders. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2012 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
FDA |
